ISHLT 2024: Integrating Barostim into a Comprehensive Heart Failure Program

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

CVRx | Barostim

CVRx® develops Barostim™ Baroreflex Activation Therapy (BAT), a novel therapy that activates the autonomic nervous system through baroreceptor stimulation to improve the symptoms of heart failure.

Learn more by visiting the following link cvrx.com

Baroreflex Activation Therapy

Playback speed

10 seconds

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

ISHLT 2024: Integrating Barostim into a Comprehensive Heart Failure Program

By CVRx | Barostim FEATURING Dmitry Yaranov

0 views

June 5, 2024

Dr. Yaranov discusses appropriate phenotypes and timing for Barostim, lifetime management of heart failure, GDMT titration and monitoring response, and real-world case experience with Barostim.

Comments 0

Baroreflex Activation Therapy